Polymeric derivative of cytidine metabolic antagonist
US7700709B2 · kind B2 · utility
13Cited by
2References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 27, 2006 |
| Grant date | Apr 20, 2010 |
| Priority date | — |
| Expiry date | Aug 5, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC08G73/028
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A derivative of a cytidine metabolic antagonist which can exert a high therapeutic effect at a low dose. A polymeric derivative of a cytidine metabolic antagonist which comprises a polymeric compound having a polyethylene glycol moiety and a polymer moiety having a carboxyl group in a side chain and a cytidine metabolic antagonist, which has such a structure that the carboxyl group in the side chain of the polymeric compound and an amino group in the cytidine metabolic antagonist are bound together to form an amide bond.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.